Atlas Trials

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

Clinical trial NCT06439992 · RECRUITING

Trial details

NCT number
NCT06439992
Sponsor
Washington University School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Alzheimer Disease
Start date
2023-11-07
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.